Product
LY3819469
4 clinical trials
3 indications
Indication
HealthyIndication
Lipoprotein DisorderIndication
Chronic Kidney DiseaseClinical trial
A Single Dose Study to Assess the Pharmacokinetics of 2 Formulations of LY3819469 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-11-07
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults With Elevated Lipoprotein(a)Status: Active (not recruiting), Estimated PCD: 2023-10-23
Clinical trial
Pharmacokinetics of LY3819469 Following Subcutaneous Dose in Participants With Renal Impairment Compared With Participants With Normal Renal FunctionStatus: Completed, Estimated PCD: 2024-01-09
Clinical trial
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3819469Status: Completed, Estimated PCD: 2022-11-09